Medicine by the Numbers

From The NNT Group, these provide short, concise, evidence-based ratings of therapies, diagnostic tests, and risk assessments commonly used in family medicine. These rating are based on patient-important benefits and harms.

Apr 1, 2017 Issue
Vitamin E in Pregnancy

Mar 1, 2017 Issue
Buprenorphine Maintenance vs. Placebo for Opioid Dependence

Feb 1, 2017 Issue
Antiepileptic Drugs After First Unprovoked Seizure

Jan 1, 2017 Issue
Alpha-adrenergic Agonists for the Management of Opioid Withdrawal

Dec 1, 2016 Issue
Aripiprazole vs. Placebo or Haloperidol for Schizophrenia

Nov 1, 2016 Issue
Valproate for Adult Migraine Prophylaxis

Oct 1, 2016 Issue
Rivaroxaban vs. Warfarin for Anticoagulation in Patients with Atrial Fibrillation Undergoing Ablation and Cardioversion
Studies showed that 433 patients needed to be treated with rivaroxaban to prevent one stroke and 629 patients needed to be treated with rivaroxaban to prevent one thromboembolic event. Read more.

Sep 1, 2016 Issue
Perioperative Beta Blockers
Studies show that 1 in 72 patients had a nonfatal myocardial infarction prevents while harm end points included nonfatal stroke, hypotension, and bradycardia. Find out more.

Aug 1, 2016 Issue
Acupuncture for Frequent Tension-Type Headaches
Studies show an NNT of 3 to have at least a 50% reduction of headache frequency compared with routine care. Want to know more?

Jul 1, 2016 Issue
Topical NSAIDs for Acute Musculoskeletal Pain in Adults
Studies show that patients had improved pain control with diclofenac gel, ketoprofen gel, and ibuprofen gel with no increase in local or systemic adverse events. See why.

Pages: 1 2 3 Next

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now